A comparative study of prescribing of hormone replacement therapy in USA and Europe

被引:54
作者
Jolleys, JV
Olesen, F
机构
[1] UNIV NOTTINGHAM,DEPT GEN PRACTICE,NOTTINGHAM NG7 2RD,ENGLAND
[2] UNIV ATHENS,RES UNIT GEN PRACTICE,AARHUS,DENMARK
关键词
hormone replacement therapy; international comparison; pharmacoepidemiology;
D O I
10.1016/0378-5122(95)00952-3
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Objectives: The use of hormone replacement therapy (HRT) has been shown to vary from one country to another through international studies of sample populations and by comparison of data obtained from comparable national studies. Drawing international prescribing comparisons is very difficult as data sources are few, incomplete and of uncertain accuracy and comparability. As an alternative to direct prescribing information, pharmaceutical sales information indicates medication used. This paper sought to demonstrate international differences in the use of HRT using an economic analysis methodology based on national pharmaceutical sales statistics. Methods: A recognised economic analysis methodology was used to translate 1991/1992 pharmaceutical sales data into women treatment years of HRT used in each country. From this was calculated the percentage of the female population in each country, eligible for HRT, who would have been taking HRT. Results: The results show a wide variance in the percentage of the eligible female population in each country calculated to have been taking HRT, from <1%-20%. The results indicated that HRT usage fell into three groupings: USA being the greatest user with UK and Scandinavian countries in the middle group and continental Europe having the lowest usage. Conclusions: National patterns of HRT usage, as calculated by this study, correlate well with those of other studies. Since similar morbidity could be expected as menopause is a naturally occurring event, not a disease, possible reasons for the variance in national prescribing patterns are discussed. The study indicates the need for further research on health beliefs and physicians' and womens' attitudes to HRT in different countries to explain the variance in HRT usage, also considering access to healthcare, in particular women's health services. It confirms the validity of using economic analysis of pharmaceutical sales data as a proxy for prescribing data in the arena of prescribing research.
引用
收藏
页码:47 / 53
页数:7
相关论文
共 20 条
[1]  
[Anonymous], 1993, ENCY BRITANNICA
[2]   HORMONE REPLACEMENT TREATMENT - DESERVES WIDER USE [J].
BELCHETZ, P .
BMJ-BRITISH MEDICAL JOURNAL, 1989, 298 (6686) :1467-1468
[3]  
BOERMA WGW, 1993, HLTH CARE GEN PRACTI
[4]   CLIMACTERIC AND MENOPAUSE IN 7 SOUTH-EAST ASIAN COUNTRIES [J].
BOULET, MJ ;
ODDENS, BJ ;
LEHERT, P ;
VEMER, HM ;
VISSER, A .
MATURITAS, 1994, 19 (03) :157-176
[5]  
COOPE J, 1993, WOMENS PROBLEM GEN P, P212
[6]   HORMONE-THERAPY TO PREVENT DISEASE AND PROLONG LIFE IN POSTMENOPAUSAL WOMEN [J].
GRADY, D ;
RUBIN, SM ;
PETITTI, DB ;
FOX, CS ;
BLACK, D ;
ETTINGER, B ;
ERNSTER, VL ;
CUMMINGS, SR .
ANNALS OF INTERNAL MEDICINE, 1992, 117 (12) :1016-1037
[7]   ESTROGEN REPLACEMENT THERAPY - WHAT THE FUTURE HOLDS [J].
HAMMOND, CB .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1989, 161 (06) :1864-1868
[8]  
*IMS INT, INT MED STAT
[9]   REGULAR REVIEW - POSTMENOPAUSAL HORMONE REPLACEMENT THERAPY [J].
JACOBS, HS ;
LOEFFLER, FE .
BMJ-BRITISH MEDICAL JOURNAL, 1992, 305 (6866) :1403-1408
[10]  
JOLLEYS JV, UNPUB